PDGFRA and systemic sclerosis: Unlike the natural, non-stimulatory, anti-PDGFRα autoantibodies, agonistic anti-PDGFRα autoantibodies recognize specific conformational epitopes, largely overlapping with the PDGF binding site, suggesting their pathogenic role in the SSc-specific, unbalanced autoimmune response against cellular antigens [19,20,21].